Why the study?
CTCA offers detailed assessment of coronary atherosclerosis and guides management, but its influence on preventative treatment in suspected ACS needed investigation.
Does early CTCA influence the subsequent use of preventative treatment in patients with suspected acute coronary syndrome?
Does early CTCA influence the subsequent use of preventative treatment in patients with suspected acute coronary syndrome?
Early CTCA in patients with suspected acute coronary syndrome facilitates targeted individualization of preventative therapies based on the extent of coronary artery disease.
Answers are grounded in this paper and cite their sources.
Early CTCA supports targeted intensification of preventative therapies in suspected ACS; extends RCT evidence for CTCA-guided management.
BACKGROUND: Computed tomography coronary angiography (CTCA) offers detailed assessment of the presence of coronary atherosclerosis and helps guide patient management. We investigated influences of early CTCA on the subsequent use of preventative treatment in patients with suspected acute coronary syndrome. METHODS: receptor antagonist, statin, renin-angiotensin system blocker, and beta-blocker therapies from randomization to discharge were compared within then between those randomized to early CTCA or to standard of care only. Effects of CTCA findings on adjustment of these therapies were further examined. RESULTS: receptor antagonist, dual antiplatelet, and statin therapies increased more in the early CTCA group (between-group difference: 4.6% [95% confidence interval, 0.3-8.9], 4.5% [95% confidence interval, 0.2-8.7], and 4.3% [95% confidence interval, 0.2-8.5], respectively), whereas prescription of other preventative therapies increased by similar extent in both study groups. Among patients randomized to early CTCA, there were additional increments of preventative treatment in those with obstructive coronary artery disease and higher rates of reductions in antiplatelet and beta-blocker therapies in those with normal coronary arteries. CONCLUSIONS: Prescription patterns of preventative treatment varied during index hospitalization in patients with suspected acute coronary syndrome. Early CTCA facilitated targeted individualization of these therapies based on the extent of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: